Research and Markets has announced the addition of the "2015 Corporate Reputation of Pharma - Analysing 10 Therapeutic Areas" report to their offering.
In 2016, the following 10 reports on Pharma Corporate Reputation as seen from the Patient Perspective will be published.
Therapeutic areas: Cancer; Circulatory conditions; Diabetes; HIV/AIDS; Hepatitis; Neurological conditions; Mental health; Skin; Respiratory and Rare diseases (10 reports).
Definition: What is a 'Patient Group'?
The definition of a 'patient group' is wide-ranging, taking in organisations that are interested in health advocacy and are relevant to patients.
'Patient group' includes not only organisations that represent individuals with a medical condition, but also:
- Carers' groups;
- Children's groups;
- Disability groups;
- Older-people's groups;
- Gender-based groups;
- Relevant research organisations;
- Semi-professional groups that involve patients.
The yardsticks for measuring corporate reputation industry-wide
- How pharma's corporate reputation compares with that of other healthcare industries.
- How pharma's corporate reputation has changed over the past five years.
- How good or bad pharma is at various activities of relevance to patients and patient groups.
What is 'Patient Advocacy'?
"Improving people's experience within healthcare by changing the healthcare environment"
For more information about this report visit http://www.researchandmarkets.com/research/jhpb23/2015_corporate
View source version on businesswire.com: http://www.businesswire.com/news/home/20161102006223/en/Business Wire
Last updated on: 02/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.